US Stock MarketDetailed Quotes

PTIXW PROTAGENIC THERAPEUTICS INC C/WTS 13/04/2025 (TO PUR COM)

Watchlist
  • 0.0225
  • 0.00000.00%
Close Apr 26 16:00 ET
0Market Cap0.00P/E (TTM)

PROTAGENIC THERAPEUTICS INC C/WTS 13/04/2025 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-85.76%-3.7M
-532.51%-1.14M
-22.52%-655.77K
-80.83%-1.53M
13.64%-371.83K
28.76%-1.99M
55.33%-180.94K
50.23%-535.23K
-19.24%-847.08K
29.15%-430.57K
Net income from continuing operations
-40.64%-5M
-178.73%-1.68M
-50.94%-1.4M
-81.42%-1.21M
47.28%-718.1K
21.39%-3.56M
32.46%-601.37K
-5.35%-925.31K
56.92%-666.72K
-12.90%-1.36M
Operating gains losses
1,268.74%630.32K
7,876.31%483.76K
96.66%23.18K
411.69%118.95K
-10.57%4.43K
156.72%46.05K
143.97%6.07K
--11.78K
--23.25K
105.92%4.96K
Depreciation and amortization
93,960.00%28.22K
88,626.67%26.62K
--1.42K
--91
--90
--30
--30
--0
--0
--0
Other non cash items
-22.59%85.77K
22.72%31.24K
-82.50%4.45K
-24.30%25.18K
-6.49%24.9K
-74.06%110.8K
-47.89%25.45K
-74.72%25.46K
-85.13%33.26K
-50.67%26.63K
Change In working capital
-121.18%-114.41K
-192.84%-176.58K
294.56%545.11K
-39.94%-633.07K
-77.40%150.13K
484.74%540.13K
-11.86%190.2K
126.09%138.15K
-314.30%-452.4K
135.14%664.18K
-Change in prepaid assets
-113.79%-87.09K
-189.48%-39.95K
1,626.13%770.6K
-545.61%-860.65K
-93.65%42.92K
231.47%631.73K
-60.75%44.64K
106.63%44.64K
-6.91%-133.31K
231.76%675.75K
-Change in payables and accrued expense
70.17%-27.33K
-193.86%-136.63K
-341.14%-225.49K
171.32%227.58K
1,026.72%107.21K
-126.93%-91.6K
42.63%145.56K
-34.97%93.51K
-2,158.54%-319.1K
-114.69%-11.57K
Cash from discontinued investing activities
Operating cash flow
-85.76%-3.7M
-532.51%-1.14M
-22.52%-655.77K
-80.83%-1.53M
13.64%-371.83K
28.76%-1.99M
55.33%-180.94K
50.23%-535.23K
-19.24%-847.08K
29.15%-430.57K
Investing cash flow
Cash flow from continuing investing activities
199.03%4.78M
1,308.25%2.28M
65.22%590.72K
128.03%1.61M
-20.52%294.67K
116.12%1.6M
-66.71%161.77K
103.44%357.53K
706.92K
370.76K
Net PPE purchase and sale
-8,197.78%-149.78K
-5,106.04%-93.97K
----
----
----
---1.81K
---1.81K
----
----
----
Net investment purchase and sale
208.06%4.93M
1,350.16%2.37M
80.83%646.53K
128.03%1.61M
-20.52%294.67K
116.13%1.6M
-66.34%163.57K
103.44%357.53K
--706.92K
--370.76K
Cash from discontinued investing activities
Investing cash flow
199.03%4.78M
1,308.25%2.28M
65.22%590.72K
128.03%1.61M
-20.52%294.67K
116.12%1.6M
-66.71%161.77K
103.44%357.53K
--706.92K
--370.76K
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position
-60.24%215.19K
-3.16%153.32K
-35.21%219.44K
-71.28%138.49K
-60.24%215.19K
-19.36%541.17K
-65.59%158.32K
-97.16%338.67K
151.56%482.18K
-19.36%541.17K
Current changes in cash
370.06%1.07M
6,013.67%1.13M
63.39%-65.05K
157.27%80.27K
-29.03%-77.17K
-203.97%-396.84K
-123.71%-19.17K
98.45%-177.7K
-101.19%-140.16K
87.56%-59.8K
Effect of exchange rate changes
-98.59%998
-98.79%920
59.83%-1.06K
120.06%671
-42.06%467
11,129.48%70.86K
38,109.05%76.04K
-40.67%-2.64K
-392.65%-3.35K
-30.82%806
End cash Position
498.49%1.29M
498.49%1.29M
-3.16%153.32K
-35.21%219.44K
-71.28%138.49K
-60.24%215.19K
-60.24%215.19K
-65.59%158.32K
-97.16%338.67K
151.56%482.18K
Free cash flow
-93.10%-3.85M
-577.68%-1.24M
-32.95%-711.57K
-80.83%-1.53M
13.64%-371.83K
28.69%-2M
54.89%-182.74K
50.23%-535.23K
-19.24%-847.08K
29.15%-430.57K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -85.76%-3.7M-532.51%-1.14M-22.52%-655.77K-80.83%-1.53M13.64%-371.83K28.76%-1.99M55.33%-180.94K50.23%-535.23K-19.24%-847.08K29.15%-430.57K
Net income from continuing operations -40.64%-5M-178.73%-1.68M-50.94%-1.4M-81.42%-1.21M47.28%-718.1K21.39%-3.56M32.46%-601.37K-5.35%-925.31K56.92%-666.72K-12.90%-1.36M
Operating gains losses 1,268.74%630.32K7,876.31%483.76K96.66%23.18K411.69%118.95K-10.57%4.43K156.72%46.05K143.97%6.07K--11.78K--23.25K105.92%4.96K
Depreciation and amortization 93,960.00%28.22K88,626.67%26.62K--1.42K--91--90--30--30--0--0--0
Other non cash items -22.59%85.77K22.72%31.24K-82.50%4.45K-24.30%25.18K-6.49%24.9K-74.06%110.8K-47.89%25.45K-74.72%25.46K-85.13%33.26K-50.67%26.63K
Change In working capital -121.18%-114.41K-192.84%-176.58K294.56%545.11K-39.94%-633.07K-77.40%150.13K484.74%540.13K-11.86%190.2K126.09%138.15K-314.30%-452.4K135.14%664.18K
-Change in prepaid assets -113.79%-87.09K-189.48%-39.95K1,626.13%770.6K-545.61%-860.65K-93.65%42.92K231.47%631.73K-60.75%44.64K106.63%44.64K-6.91%-133.31K231.76%675.75K
-Change in payables and accrued expense 70.17%-27.33K-193.86%-136.63K-341.14%-225.49K171.32%227.58K1,026.72%107.21K-126.93%-91.6K42.63%145.56K-34.97%93.51K-2,158.54%-319.1K-114.69%-11.57K
Cash from discontinued investing activities
Operating cash flow -85.76%-3.7M-532.51%-1.14M-22.52%-655.77K-80.83%-1.53M13.64%-371.83K28.76%-1.99M55.33%-180.94K50.23%-535.23K-19.24%-847.08K29.15%-430.57K
Investing cash flow
Cash flow from continuing investing activities 199.03%4.78M1,308.25%2.28M65.22%590.72K128.03%1.61M-20.52%294.67K116.12%1.6M-66.71%161.77K103.44%357.53K706.92K370.76K
Net PPE purchase and sale -8,197.78%-149.78K-5,106.04%-93.97K---------------1.81K---1.81K------------
Net investment purchase and sale 208.06%4.93M1,350.16%2.37M80.83%646.53K128.03%1.61M-20.52%294.67K116.13%1.6M-66.34%163.57K103.44%357.53K--706.92K--370.76K
Cash from discontinued investing activities
Investing cash flow 199.03%4.78M1,308.25%2.28M65.22%590.72K128.03%1.61M-20.52%294.67K116.12%1.6M-66.71%161.77K103.44%357.53K--706.92K--370.76K
Financing cash flow
Cash flow from continuing financing activities
Cash from discontinued financing activities
Net cash flow
Beginning cash position -60.24%215.19K-3.16%153.32K-35.21%219.44K-71.28%138.49K-60.24%215.19K-19.36%541.17K-65.59%158.32K-97.16%338.67K151.56%482.18K-19.36%541.17K
Current changes in cash 370.06%1.07M6,013.67%1.13M63.39%-65.05K157.27%80.27K-29.03%-77.17K-203.97%-396.84K-123.71%-19.17K98.45%-177.7K-101.19%-140.16K87.56%-59.8K
Effect of exchange rate changes -98.59%998-98.79%92059.83%-1.06K120.06%671-42.06%46711,129.48%70.86K38,109.05%76.04K-40.67%-2.64K-392.65%-3.35K-30.82%806
End cash Position 498.49%1.29M498.49%1.29M-3.16%153.32K-35.21%219.44K-71.28%138.49K-60.24%215.19K-60.24%215.19K-65.59%158.32K-97.16%338.67K151.56%482.18K
Free cash flow -93.10%-3.85M-577.68%-1.24M-32.95%-711.57K-80.83%-1.53M13.64%-371.83K28.69%-2M54.89%-182.74K50.23%-535.23K-19.24%-847.08K29.15%-430.57K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg